Alps Advisors Inc Vista Gen Therapeutics, Inc. Transaction History

Alps Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.88 - $1.73 $186,786 - $367,204	-212,257 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.14 - $2.09 $21,503 - $39,423	-18,863 Reduced 8.16%	212,257 $263,000
Q4 2021 Feb 09, 2022	SELL	$1.67 - $2.76 $8,882 - $14,680	-5,319 Reduced 2.25%	231,120 $451,000
Q3 2021 Nov 15, 2021	BUY	$2.62 - $3.45 $130,486 - $171,823	49,804 Added 26.69%	236,439 $648,000
Q2 2021 Aug 11, 2021	BUY	$1.96 - $3.15 $365,804 - $587,900	186,635 New	186,635 $588,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $730M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.